Rethinking Addiction as a Chronic Brain Disease
The New York Times
Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs.
The message emblazoned on a walkway window at the airport in Burlington, Vt., is a startling departure from the usual tourism posters and welcome banners:
“Addiction is not a choice. It’s a disease that can happen to anyone.”
The statement is part of a public service campaign in yet another community assailed by drug use, intended to reduce stigma and encourage treatment.
For decades, medical science has classified addiction as a chronic brain disease, but the concept has always been something of a hard sell to a skeptical public. That is because, unlike diseases such as Alzheimer’s or bone cancer or Covid, personal choice does play a role, both in starting and ending drug use. The idea that those who use drugs are themselves at fault has recently been gaining fresh traction, driving efforts to toughen criminal penalties for drug possession and to cut funding for syringe-exchange programs.
But now, even some in the treatment and scientific communities have been rethinking the label of chronic brain disease.
In July, behavior researchers published a critique of the classification, which they said could be counterproductive for patients and families.
On Monday night you may have a chance to witness the moon obscuring the Red Planet at its brightest, as well as a comet’s closest approach to the sun.
The maker of ChatGPT hopes to spur investment from the Middle East and avoid strict regulations on the development of new technologies.
Outbreaks among the unvaccinated are a predictable consequence of falling immunization rates. But even vaccinated adults may be vulnerable to some illnesses.
The flight, postponed more than hour into its launch window, is a crucial moment for the company’s vision for space, and a test of whether it may emerge as a serious competitor to Elon Musk and SpaceX.
Days into the new charges, some restaurant owners say suppliers are raising prices. Others are giving customer discounts, and many fear the fallout for workers.
If New Glenn lifts off overnight as planned, the Amazon founder’s rocket company will be on track to give Elon Musk’s SpaceX some genuine competition.
Scientists have identified a gene that causes production of a substance in some citrus that interferes with many medications.
After visiting President-elect Donald J. Trump in November, Mr. Zuckerberg decided to relax Meta’s speech policies. He asked a small team to carry out his goals within weeks. The repercussions are just beginning.
Adding crispy sheet-pan gnocchi makes for an easy, texturally delightful one-pan meal in this recipe from Melissa Clark.
Billions in advertising flows through TikTok, which could be banned in the U.S. as soon as Jan. 19. Brands and creators are racing to prepare.
Charon is large in size relative to Pluto, and is locked in a tight orbit with the dwarf planet. A new simulation suggests how it ended up there.
The results of a new federal analysis were drawn from studies conducted in other countries, where drinking water contains more fluoride than in the United States.
It’s not causing panic! in the fossil record, but a 430-million-year-old mollusk discovery in Britain is a source of excitement for some scientists.
The surgeon general’s call to arms about the link between drinking and cancer could strike at a fiscal lifeline for restaurateurs facing falling sales.
The Mars Sample Return effort was billions of dollars over budget and not expected to return to Earth with its samples until 2040.
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.
The social networking giant will stop using third-party fact checkers and instead rely on users to add notes to posts. It is likely to please President-elect Trump and his conservative allies.
Venomous snakes bite millions of people worldwide each year, killing at least 120,000. Many of them are poor people in rural areas of Africa without easy access to treatment.